This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Edwards Lifesciences Corp (EW)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 811.10M 391.70M 293.20M 236.70M
Operating Gains/Losses 0.00 13.60M 14.20M 22.20M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -26.80M 8.50M -26.50M -53.70M
(Increase) Decrease in Inventories -30.50M -44.40M -21.70M -57.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 112.90M 50.30M 41.90M 61.70M
(Decrease) Increase In Other Current Liabilities 128.10M 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 7.50M 2.50M 5.00M -1.30M
Other Non-Cash Items 23.40M -22.90M -10.50M 27.90M
Net Cash From Continuing Operations 1.02B 472.70M 373.80M 314.50M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.02B 472.70M 373.80M 314.50M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 526.40M 662.30M 349.90M
Purchases of Property, Plant & Equipment -93.70M -110.10M -127.70M -90.60M
Acquisitions -15.00M 0.00 -36.60M -42.60M
Purchases of Short-Term Investments 0.00 -823.20M -592.60M -643.30M
Other Cash from Investing Activities -515.20M -3.10M 3.30M 7.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -633.00M -412.70M -90.50M -412.80M
Issuance of Debt 226.30M 1.30B 407.00M 526.10M
Cash Used for Financing Activities
Issuance of Capital Stock 113.30M 45.50M 100.10M 59.50M
Repayment of Long-Term Debt -239.00M -895.40M -367.50M -421.70M
Repurchase of Capital Stock -300.90M -496.90M -344.10M -303.40M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 47.30M 76.70M 48.90M 4.30M
Net Cash From Financing Activities -153.00M 34.90M -155.60M -135.20M
Effect of Exchange Rate Changes -2.90M 14.60M 12.00M 8.60M
Net Change in Cash & Cash Equivalents 233.40M 109.50M 139.70M -224.90M
EW News

EW Edwards Lifesciences Corp

Chart of EW

Analysts Ratings for EW

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 9 9
Moderate Buy 2 2 0 0
Hold 4 4 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

EW Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs